- Home
- IIPR vs ATRC Comparison
IIPR vs ATRC Comparison
Compare IIPR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIPR
- ATRC
- Stock Information
- Founded
- IIPR 2016
- ATRC 2000
- Country
- IIPR United States
- ATRC United States
- Employees
- IIPR N/A
- ATRC N/A
- Industry
- IIPR Real Estate
- ATRC Medical/Dental Instruments
- Sector
- IIPR Finance
- ATRC Health Care
- Exchange
- IIPR Nasdaq
- ATRC Nasdaq
- Market Cap
- IIPR 1.5B
- ATRC 1.7B
- IPO Year
- IIPR 2016
- ATRC 2005
- Fundamental
- Price
- IIPR $57.28
- ATRC $36.43
- Analyst Decision
- IIPR Hold
- ATRC Strong Buy
- Analyst Count
- IIPR 8
- ATRC 10
- Target Price
- IIPR $88.75
- ATRC $49.60
- AVG Volume (30 Days)
- IIPR 258.1K
- ATRC 377.2K
- Earning Date
- IIPR 11-05-2025
- ATRC 10-28-2025
- Dividend Yield
- IIPR 13.31%
- ATRC N/A
- EPS Growth
- IIPR N/A
- ATRC N/A
- EPS
- IIPR 4.63
- ATRC N/A
- Revenue
- IIPR $287,883,000.00
- ATRC $499,946,000.00
- Revenue This Year
- IIPR N/A
- ATRC $16.32
- Revenue Next Year
- IIPR N/A
- ATRC $12.37
- P/E Ratio
- IIPR $12.32
- ATRC N/A
- Revenue Growth
- IIPR N/A
- ATRC 16.28
- 52 Week Low
- IIPR $45.44
- ATRC $25.57
- 52 Week High
- IIPR $138.35
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- IIPR 59.50
- ATRC 52.95
- Support Level
- IIPR $55.48
- ATRC $34.57
- Resistance Level
- IIPR $57.68
- ATRC $36.80
- Average True Range (ATR)
- IIPR 1.30
- ATRC 1.30
- MACD
- IIPR 0.18
- ATRC -0.14
- Stochastic Oscillator
- IIPR 83.66
- ATRC 51.01
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.